Cadmium, environmental exposure, and health outcomes.

Satarug S, Garrett SH, Sens MA, Sens DA. · 2010

Read Cadmium, environmental exposure, and health outcomes. by Satarug S, Garrett SH, Sens MA, Sens DA. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2831915.txt.

Introduction

Satarug, Garrett, Sens, and Sens updated the health evidence in 2010 on cadmium, a toxic metal that slips into most foods from soil. Diet is the main source for nonsmokers, and the body absorbs cadmium by borrowing the transport routes meant for calcium, iron, zinc, and manganese. Reviewed studies ran from 2004 to 2009.

Cadmium builds up in kidneys, eyes, and other organs, and kidney and bone harm appeared in the general public more often than safety models predicted. Harm showed up at urine levels far below the threshold behind the current weekly intake limit. Evidence also linked cadmium to diseases beyond kidney and bone, which leads the authors to question the safe limit itself.

Catalog record

CREATORSatarug S, Garrett SH, Sens MA, Sens DA.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE63 KB
LICENSECC0 1.0 Universal
RIGHTSCC0
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2831915

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Cadmium, Environmental Exposure, and Health Outcomes By Soisungwan Satarug, Scott H Garrett, Mary Ann Sens, Donald A Sens Published in: Environmental Health Perspectives DOI: 10.1289/ehp.0901234 ABSTRACT Abstract Objectives We provide an update of the issues surrounding health risk assessment of exposure to cadmium in food. Data sources We reviewed epidemiologic studies published between 2004 and 2009 concerning the bioavailability of cadmium in food, assessment of exposure, and body burden estimate, along with exposure-related effects in nonoccupationally exposed populations. Data extraction and synthesis Bioavailability of ingested cadmium has been confirmed in studies of persons with elevated dietary exposure, and the findings have been strengthened by the substantial amounts of cadmium accumulated in kidneys, eyes, and other tissues and organs of environmentally exposed individuals. We hypothesized that such accumulation results from the efficient absorption and systemic transport of cadmium, employing multiple transporters that are used for the body’s acquisition of calcium, iron, zinc, and manganese. Adverse effects of cadmium on kidney and bone have been observed in environmentally exposed populations at frequencies higher than those predicted from models of exposure. Increasing evidence implicates cadmium in the risk of diseases that involve other tissues and organ systems at cadmium concentrations that do not produce effects on bone or renal function. Conclusions Population data raise concerns about the validity of the current safe intake level that uses the kidney as the sole target in assessing the health risk from ingested cadmium. The data also question the validity of incorporating the default 5% absorption rate in the threshold-type risk assessment model, known as the provisional tolerable weekly intake (PTWI), to derive a safe intake level for cadmium. Keywords: cadmium, calcium, cancer, diet, disease burden, environmental exposure, iron, manganese, zinc Because of its high rates of soil-to-plant transfer, cadmium is a contaminant found in most human foodstuffs, which renders diet a primary source of exposure among nonsmoking, nonoccupationally exposed populations (Clemens 2006; Franz et al. 2008; McLaughlin et al. 2006). A safe intake limit of 7 μg cadmium/week/kg body weight was set based on the critical renal cadmium concentration of between 100 and 200 μg/g wet weight that corresponds to a urinary threshold limit of 5–10 μg/g creatinine [World Health Organization (WHO) 1989, 1993]. However, numerous studies have revealed adverse kidney effects at urinary cadmium levels < 0.5 μg/g creatinine (Satarug and Moore 2004). Further, accumulating evidence links environmental exposure to cadmium with increased cancer incidence. For example, in prospective studies in Japan and the United States, excess cancer mortality was found to be associated with environmental exposure to cadmium (Arisawa et al. 2007b; Menke et al. 2009; Nishijo et al. 2006). Åkesson et al. (2008) observed increased endometrial cancer risk in a Swedish cohort among participants who consumed > 15 μg/day of cadmium, mainly from cereals and vegetables. These findings suggest a very large health burden associated with exposure to cadmium at levels experienced by many populations worldwide. This review provides an update on cadmium exposure levels and the potential adverse health effects they may elicit in adult populations. We focus first on key issues underpinning health risk assessment of low-level cadmium in the diet, including bioavailability of dietary origin, the 5% default absorption rate, thresholds and safe intake levels, and the kidney as a specific target for cadmium accumulation. Second, we review epidemiologic studies from 2004 to 2009 that link exposure levels to observed effects in classic targets (kidney and bone) along with newly identified potential target organs. We also summarize evidence that links cadmium with diabetes, diabetic nephropathy, hypertension, peripheral artery disease (PAD), myocardial infarction, diminished lung function, periodontal disease, and age-related macular degeneration (AMD). Evidence from prospective studies reveal potential causal relationships of cadmium exposure with life prognosis (all-cause mortality) and excess cancer mortality and suggest that cadmium is at least a comorbidity factor if not a causative factor. Specifically, we summarize cadmium-cancer associations for the lung, pancreas, breast, endometrium, prostate, and urinary bladder. FAO/WHO GUIDELINES FOR SAFE INTAKE The major issue addressed in this article is whether the guidelines established for the safe intake of cadmium adequately protect individuals from increased health risk. The Food and Agriculture Organization/World Health Organization (FAO/WHO) Joint Expert Committee on Food Additives has defined the provisional tolerable weekly intake (PTWI) for a chemical with no intended function as an estimate of the amount of the chemical that can be ingested weekly over a lifetime without appreciable health risk (WHO 1989). The PTWI value initially set for cadmium was 400–500 μg/person/week (WHO 1989). These levels were based on a critical renal concentration of 100–200 μg cadmium/g wet kidney cortex weight, attained after a cadmium intake of 140–260 μg/day for > 50 years or 2,000 mg over a lifetime (WHO 1989). The PTWI model incorporates an oral absorption rate of 5% and a daily excretion rate of 0.005% of total body burden. In 1992, the PTWI for cadmium was refined and subsequently expressed in terms of cadmium intake per kilogram of body weight (WHO 1993). This refinement also recognized that the model PTWI for cadmium did not include a safety factor and that only a very modest margin existed between the level of exposure in a normal diet and a level predicted to produce a potential effect on the kidney. Despite this narrow safety factor, the PTWI for cadmium was retained at 7 μg/kg body weight, which translates to 70 μg/day for a person who weighs 70 kg. A toxicokinetic model predicts, based on similar assumptions, that the renal cortical cadmium level of 50 μg/g wet weight could be attained at the cadmium intake of 1 μg/kg body weight/day over 50 years (Buchet et al. 1990). The renal cortical cadmium 50 μg/g wet weight corresponds to urinary cadmium 2 μg/g creatinine, but kidney effects have been observed at urinary cadmium levels < 0.5 μg/g creatinine (Table 1). These findings argue that the current safe intake level does not provide sufficient health protection and that it should be lowered. [Table: Exposure levels associated with kidney and bone effects.] Satarug et al. (2000, 2003) examined the PTWI model by studying cadmium accumulation in kidneys and livers of environmentally exposed subjects. Their studies suggested that the safe intake level for an adult should be < 30 μg/day. They also showed that cadmium accumulation in the kidney cortex increased with age, reaching a plateau by 50 years of age (Satarug et al. 2002). An estimated dietary intake at 25–30 μg cadmium/day for persons in the 41- to 50-year-old age group would give rise to a total cadmium body burden of 18 mg. The studies indicated that the estimated intake of 25–30 μg/day may produce adverse kidney effects in about 1% of the adult population when variability in absorption and sensitivity to adverse effects among population members are considered in the analysis. THRESHOLD-BASED MODELS FOR SAFE INTAKE If the relative susceptibility of humans and animals is unknown at the time of derivation of PTWI, the lowest observed adverse effect level (LOAEL) in the most sensitive species is used, which adds an uncertainty factor of 100. Thus, the PTWI value must be substantiated by additional experimental data, and, if warranted, a larger uncertainty factor should be applied to the value. An alternative to LOAEL,

Read the complete text